Privia Health Group
PRVANASDAQUSD
- Source valuation snapshot. Not a live recalculation.
- Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
- Diluted earnings per share from the latest filed annual.
- $24.04 Prior regular-session close from the quote source.
- $23.65–$24.47 Regular-session low and high so far today.
- 1.3M Regular-session shares traded · Nov 12, 4:00 PM ET.
- Feb 25 projected Projected for 2027-02-25 from the company’s own results filings (SEC 8-K Item 2.02). The company has not confirmed the date.
- $18.92–$28.82 52-week trading low and high returned by the quote source.
Understand the Business
Why the Stock Moved
Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.
The core investment thesis
Own PRVA if Privia is a cash-generative bet that independent physicians will outsource the complexity of value-based contracting and practice operations to its enablement platform rather than sell into hospitals or insurer-owned groups.
PRVA price history
Loading recent earnings…
Investment thesis
What must happen next
Privia’s physician-enablement proposition keeps winning practices that want contracting and operating scale without hospital or insurer employment, so provider-market expansion continues to convert into revenue.StrengtheningMateriality: High
GAAP annual revenue increased from $966.2 million in FY2021 to $2.123 billion in FY2025. If physicians keep choosing Privia, the company has a long runway; if they choose employment or rival platforms, the growth engine stalls before margins can scale.
Watch: Local hospital systems accelerate physician employment and make independent-practice affiliation less attractive.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
GAAP annual revenue increased from $966.2 million in FY2021 to $2.123 billion in FY2025.
Open source ↗Privia’s value-based-care and practice-services model produces cash rather than consuming capital because it enables physicians without taking uncontrolled insurer-like medical-cost risk.StrengtheningMateriality: High
GAAP annual operating cash flow was positive in FY2022, FY2023, FY2024, and FY2025. Cash conversion makes growth fundable and lowers balance-sheet risk; a shift toward poorly priced risk contracts would turn growth into a capital drain.
Watch: CMS or commercial payers materially lower shared-savings opportunities, benchmarks, or risk-adjustment payments.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
GAAP annual operating cash flow was positive in FY2022, FY2023, FY2024, and FY2025.
Open source ↗The centralized technology and operating platform scales across affiliated practices, so incremental growth should increasingly show up as GAAP operating profit rather than only larger gross billings.StrengtheningMateriality: Medium
GAAP annual operating income improved from a loss of $217.4 million in FY2021 to positive $34.2 million in FY2025. Operating leverage is what turns a physician-network growth story into durable equity value; without it, Privia remains a low-margin healthcare services company.
Watch: New markets require heavy local staffing, sales, and medical-group infrastructure that prevents centralized platform leverage.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
GAAP annual operating income improved from a loss of $217.4 million in FY2021 to positive $34.2 million in FY2025.
Open source ↗Privia’s cash-rich balance sheet lets it fund market expansion, technology investment, and selective partnerships without being forced into dilutive or debt-financed growth.StrengtheningMateriality: Medium
Cash was $479.7 million at FY2025 year-end. A strong balance sheet gives management time to build markets through healthcare contracting cycles; if cash is spent poorly or risk contracts absorb capital, strategic optionality shrinks.
Watch: Management uses cash for overpriced acquisitions or market launches that do not attract physicians and payer contracts.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
Cash was $479.7 million at FY2025 year-end.
Open source ↗The model must translate network scale into per-share earnings through margin expansion and disciplined equity compensation, not just higher revenue.HoldingMateriality: Medium
GAAP diluted EPS improved from a loss of $1.83 in FY2021 to positive $0.18 in FY2025. Owners only benefit if growth compounds per share; if stock compensation, dilution, or thin margins absorb the economics, the business can grow while the stock disappoints.
Watch: Equity compensation or acquisition-related issuance increases the share count faster than operating profit grows.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
GAAP diluted EPS improved from a loss of $1.83 in FY2021 to positive $0.18 in FY2025.
Open source ↗
Full investment case & evidence
Loading the original research archive…
Original research
Privia’s physician-enablement proposition keeps winning practices that want contracting and operating scale without hospital or insurer employment, so provider-market expansion continues to convert into revenue. If physicians keep choosing Privia, the company has a long runway; if they choose employment or rival platforms, the growth engine stalls before margins can scale.
Privia’s value-based-care and practice-services model produces cash rather than consuming capital because it enables physicians without taking uncontrolled insurer-like medical-cost risk. Cash conversion makes growth fundable and lowers balance-sheet risk; a shift toward poorly priced risk contracts would turn growth into a capital drain.
The centralized technology and operating platform scales across affiliated practices, so incremental growth should increasingly show up as GAAP operating profit rather than only larger gross billings. Operating leverage is what turns a physician-network growth story into durable equity value; without it, Privia remains a low-margin healthcare services company.
Privia’s cash-rich balance sheet lets it fund market expansion, technology investment, and selective partnerships without being forced into dilutive or debt-financed growth. A strong balance sheet gives management time to build markets through healthcare contracting cycles; if cash is spent poorly or risk contracts absorb capital, strategic optionality shrinks.
The model must translate network scale into per-share earnings through margin expansion and disciplined equity compensation, not just higher revenue. Owners only benefit if growth compounds per share; if stock compensation, dilution, or thin margins absorb the economics, the business can grow while the stock disappoints.
All standing thesis claims
Original report summary
Privia is a cash-generative bet that independent physicians will outsource the complexity of value-based contracting and practice operations to its enablement platform rather than sell into hospitals or insurer-owned groups.
Bull case and bear case
Bull case and bear case for Privia Health Group
Where the evidence on Privia Health Group stands: Holding on the latest evidence (Nov 12, 2026). Of its 5 thesis points, 4 strengthening and 1 holding.
Bull case: what the evidence supports
Privia’s physician-enablement proposition keeps winning practices that want contracting and operating scale without hospital or insurer employment, so provider-market expansion continues to convert into revenue.
Privia’s value-based-care and practice-services model produces cash rather than consuming capital because it enables physicians without taking uncontrolled insurer-like medical-cost risk.
The centralized technology and operating platform scales across affiliated practices, so incremental growth should increasingly show up as GAAP operating profit rather than only larger gross billings.
Privia’s cash-rich balance sheet lets it fund market expansion, technology investment, and selective partnerships without being forced into dilutive or debt-financed growth.
The model must translate network scale into per-share earnings through margin expansion and disciplined equity compensation, not just higher revenue.
Bear case: what would count against it
Local hospital systems accelerate physician employment and make independent-practice affiliation less attractive.
CMS or commercial payers materially lower shared-savings opportunities, benchmarks, or risk-adjustment payments.
New markets require heavy local staffing, sales, and medical-group infrastructure that prevents centralized platform leverage.
Thesis-Break Engine
Thesis-break watch · Privia Health Group
No break has crossed Privia Health Group’s thesis. Its break conditions are checked against every new filing as it lands.
MARKET + FINANCIAL SNAPSHOT
The numbers behind the thesis
What Changed
- MixedReported results of operations (earnings release).
Privia Health Group filed an SEC 8-K on 2026-11-05: Reported results of operations (earnings release). It is a dated development that tests the current thesis.
- MixedDirector or principal officer change.
Privia Health Group filed an SEC 8-K on 2026-08-18: Director or principal officer change. It is a dated development that tests the current thesis.
- MixedReported results of operations (earnings release).
Privia Health Group filed an SEC 8-K on 2026-08-06: Reported results of operations (earnings release). It is a dated development that tests the current thesis.
Risks / falsifiers
What could break the thesis
- Local hospital systems accelerate physician employment and make independent-practice affiliation less attractive.
- CMS or commercial payers materially lower shared-savings opportunities, benchmarks, or risk-adjustment payments.
- New markets require heavy local staffing, sales, and medical-group infrastructure that prevents centralized platform leverage.
- Management uses cash for overpriced acquisitions or market launches that do not attract physicians and payer contracts.
- Equity compensation or acquisition-related issuance increases the share count faster than operating profit grows.
PRVA news
Loading headlines…
Financial statements
PRVA income statement
Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.
PRVA: quick answers
- When does Privia Health Group (PRVA) report earnings next?
- Privia Health Group's next results are projected for February 25, 2027, from the dates of its own results filings with the SEC. The company has not confirmed the date. It last reported on November 5, 2026. Earnings calendar
- What is PRVA's short interest?
- As of October 30, 2026, 3.9M PRVA shares were sold short, 3.05% of its shares outstanding, down 22.2% from the count before. At the stock's average daily volume that is 4.5 days to cover. FINRA publishes the count twice a month. PRVA short interest history
- Which well-known investors own PRVA?
- 1 of the 37 well-known funds tracked here reported PRVA shares in their latest 13F filing. By share of the fund's portfolio: Durable Capital Partners, 2.9%. Fund portfolios
PRVA in well-known investors’ portfolios
1 of 37 funds reported PRVA shares in their latest 13F filing. A 13F shows quarter-end positions and arrives up to 45 days later.
| Fund | Of its portfolio | Value | Change | Quarter |
|---|---|---|---|---|
| Durable Capital Partners | 2.9% | $299M | −3.7% | Q2 2026 |
